Effectiveness of Robot-assisted Gait Training Versus Conventional Therapy on Mobility in Severely Disabled Multiple Sclerosis Patients

CompletedNot a drug-phase studyMS (type not specified)NCT02421731

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Robot-assisted gait training

Compared with

  • Conventional therapy

What it measured

Main measures

  • Timed 25 Foot Walk

    weeks: 0,2,4,16

    Disability progressionWalking and mobility

Other measures (9)

  • Six-Minute Walking Test

    weeks: 0,2,4,16

    Walking and mobility
  • Berg Balance Scale

    weeks: 0,2,4,16

    Walking and mobility
  • Up and Go Test

    weeks: 0,2,4,16

    Walking and mobility
  • Fatigue Severity Scale

    weeks: 0,2,4,16

    Fatigue
  • Modified Ashworth Scale

    weeks: 0,2,4,16

    Spasticity
  • Short-Form 36

    weeks: 0,2,4,16

    Quality of life (reported by participants)
  • Haemodynamic measurements

    weeks: 0,2,4,16

  • Metabolic measurements by Near infrared spectroscopy

    weeks: 0,2,4,16

    Walking and mobility
  • Circulating biomarkers

    weeks: 0,2,4,16

    Blood or spinal fluid markers

Who could take part

MS (type not specified) · 18 to 65 · EDSS 6 to 7

Show the full criteria

Inclusion criteria

* severe gait impairments defined as EDSS 6-7 * lack of EDSS worsening in the last 3 months

Exclusion criteria

* neurologic conditions in addition to MS that may affect motor function and other medical conditions likely to interfere with the ability to safely complete the study protocol * impaired cognitive functioning: score less than 24 on the Mini Mental State Examination * spasticity (Ashworth scale >3) or contractures that may limit range of motion or function * changes in disease modifying drug therapy or in any other confounding factor during the study.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Gait disabilities affect personal activities and quality of life of progressive multiple sclerosis (MS) patients. A robot-driven gait orthosis allowing a more effective support of walking movements and imitation of a nearly normal gait pattern during treadmill training at a higher speed has been developed and recently introduced in clinical settings. However, until now few studies evaluated the effects of Robot-Assisted Gait Training (RAGT) in a group of stroke, spinal cord injury and MS subjects. In addition, the training-induced neural and biological changes potentially related to the mechanisms of recovery remain undefined. The primary aims of this study are: to test the feasibility of RAGT in a group of progressive severely disabled MS patients and to test the hypothesis that this intensive intervention could have higher benefit, compared with conventional therapy alone, in mobility improvement as assessed by the Timed 25 Foot Walk (T25FW) The secondary aims of this study are: to determine whether fatigue, Quality of life, balance and locomotor function are improved by RAGT; to determine whether gait training influences markers of plasticity including clinical and circulating biomarkers to search for a possible correlation between clinical outcomes and clinical and circulating biomarkers

Papers

Loading reviews and guidelines…

History

    1. Started

      Feb 2014

    2. Main results due

      Feb 2018

    3. Finished

      Feb 2018

    Assembled by software from public sources.